AKT1 and metabolic dysfunction-associated steatotic liver disease: Based on the KEGG enrichment analysis, it could be seen that the alleviating effect of FA on NAFLD mainly involved ROS, the HIF-1 signaling pathway, lipids and atherosclerosis, insulin resistance, and the PI3K-Akt signaling pathway, which mediated the potential mechanism of FA intervention in NAFLD (Figure 5d).